Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers

Fig. 1

Ascites levels of inflammation-regulating factors in serous EOC patients and those with benign conditions. Box plots representing ascites levels of IL-6 (a), IL-10 (b), leptin (c), suPAR (d), CCL18 (e) and OPG (f) in patients with advanced serous EOC and patients with benign gynecological conditions. (g) Box plot of serum CA125 levels in serous EOC patients and patients with benign gynecological diseases. The P value is indicated for each factor. ROC analysis using leptin, suPAR and CCL18 (h), and IL-6, IL-10 and OPG (i) for distinguishing patients with serous EOC from control patients. (j) ROC analysis of serum CA125 for distinguishing serous EOC from control patients

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us